Browse the complete record of transactions filed by Doherty James J., Directeur Digital. Director active across 1 companies, notably Acumen Pharmaceuticals, Inc.. Cumulatively, 2 disclosures have been recorded. Total volume traded: €6k. The latest transaction was filed on 7 January 2026 — Cession. Regulator: SEC (Form 4). All data is free.
2 of 2 declarations
James J. Doherty serves as President and Chief Development Officer at Acumen Pharmaceuticals, Inc. He is responsible for the strategic and operational direction of the company, ensuring that growth objectives are met. James has a strong background in the industry, enabling him to effectively lead his teams towards operational excellence. His commitment to innovation and sustainability is central to his mission.